RxDoctor Payments Data

Stuart Gordon, MD

Gastroenterology · Lebanon, NHNPI 1992711469

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (55.0%), speaking fees and travel and lodging — rather than concentrated in one kind of arrangement. Boston Scientific accounts for 90.4% of it on its own, with 4 other manufacturers making up the rest. Reporting peaked in 2023 at $21,505 and has fallen 98.4% since, to $350 in 2025. Among gastroenterology clinicians in NH with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$42,213in general payments, 2019–2025

Across 36 payments — averaging $1172.58 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boston Scientific$38K
  • Ipsen Biopharmaceuticals, Inc$3K
  • Vascular Technology, Inc.$350
  • Lumendi LLC$236
  • Fujifilm Healthcare Americas Corporation$147
$50,998in research payments, 2019–2025

Across 15 payments — averaging $3399.86 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Erbe Elektromedizin GmbH$41K
  • US Endoscopy$10K

What the payments were for

  • Consulting fees$23,22555%
  • Speaking & faculty fees$16,17038%
  • Travel & lodging$2,3246%
  • Food & beverage$4941%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$42,213 in reported general payments places this provider in the 90th percentile of 91 gastroenterology providers in New Hampshire.

See all gastroenterology providers in New Hampshire

Medicare billing

Part B allowed, 2024
$141,336
Medicare patients
504
Services billed
997

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
CreonLipase/Protease/Amylase28$57,565
Omeprazole127$2,467
Esomeprazole Magnesium18$1,600
Pantoprazole Sodium69$860
Oxycodone Hcl55$809
Morphine Sulfate ErMorphine Sulfate11$189
Prednisone14$117
Ciprofloxacin Hcl21$59

Paid to pharmacies, not to this prescriber.

Other gastroenterology in Lebanon

See the full list for New Hampshire

Where these figures come from

Is this you, or does something look wrong? →